Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
QCLS stock price ended at $3.95 on 星期三, after dropping 1.74%
On the latest trading day Mar 18, 2026, the stock price of QCLS fell by 1.74%, dropping from $4.11 to $3.95. During the session, the stock saw a volatility of 6.41%, with prices oscillating between a daily low of $3.90 and a high of $4.15. On the latest trading day, the trading volume for QCLS decreased by 194.2K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 275.6K shares were traded, with a market value of approximately $16.4M.